Skip to main content
Government Resource

Important information for the safe use of Tussionex Pennkinetic Extended-Release Suspension.

FDA Consumer Health Information. Silver Spring, MD: US Food and Drug Administration; March 11, 2008.

Save
Print
March 26, 2008
FDA Consumer Health Information. Silver Spring, MD: US Food and Drug Administration; March 11, 2008.

This announcement alerts parents and health care professionals about the potentially fatal dangers of Tussionex Pennkinetic Extended-Release Suspension, a prescription cough medicine that should not be used in children younger than 6 years.